Literature DB >> 16581830

The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells?

Abdelilah Soussi Gounni1.   

Abstract

The airway smooth muscle (ASM) has been typically described as a contractile tissue, responding to neurotransmitters and inflammatory mediators. However, it has recently been recognized that ASM cells can also secrete cytokines and chemokines and express cell adhesion molecules that are important for the perpetuation and modulation of airway inflammation. Recent progress has revealed the importance of IgE Fc receptors in stimulating and modulating the function of these cells. In particular, the high-affinity receptor for IgE (FcepsilonRI) has been identified in primary human ASM cells in vitro and in vivo within bronchial biopsies of atopic asthmatic individuals. Moreover, activation of this receptor has been found to induce marked increases in the intracellular calcium concentrations and T helper 2 cytokines and chemokines release. This and other evidence discussed in this review provide an emerging view of FcepsilonR/IgE network as a critical modulator of ASM cell function in allergic asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581830     DOI: 10.1152/ajplung.00005.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

Review 1.  Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways.

Authors:  Omar Tliba; Yassine Amrani
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 2.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 3.  Exploring lung physiology in health and disease with lung slices.

Authors:  Michael J Sanderson
Journal:  Pulm Pharmacol Ther       Date:  2011-05-12       Impact factor: 3.410

Review 4.  Mechanistic systems biology of inflammatory gene expression in airway smooth muscle as tool for asthma drug development.

Authors:  Chi-Ming Hai
Journal:  Curr Drug Discov Technol       Date:  2008-12

5.  Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1.

Authors:  Omar Tliba; Gautam Damera; Audreesh Banerjee; Su Gu; Hasna Baidouri; Stefan Keslacy; Yassine Amrani
Journal:  Am J Respir Cell Mol Biol       Date:  2007-10-18       Impact factor: 6.914

6.  Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production.

Authors:  Jingbo Zhang; Lianyu Shan; Latifa Koussih; Naresh Singh Redhu; Andrew J Halayko; Jamila Chakir; Abdelilah S Gounni
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

7.  Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?

Authors:  Michael Roth
Journal:  J Allergy (Cairo)       Date:  2011-11-02

8.  IL-13 R110Q, a Naturally Occurring IL-13 Polymorphism, Confers Enhanced Functional Activity in Cultured Human Bronchial Smooth Muscle Cells.

Authors:  Ya-Fang He; Li Hua; Yi-Xiao Bao; Quan-Hua Liu; Yi Chu; Ding-Zhu Fang
Journal:  Allergy Asthma Immunol Res       Date:  2013-08-07       Impact factor: 5.764

9.  Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells.

Authors:  Naresh Singh Redhu; Ali Saleh; Lianyu Shan; William T Gerthoffer; Sam K Kung; Andrew J Halayko; Bouchaib Lamkhioued; Abdelilah S Gounni
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

10.  IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways.

Authors:  Naresh Singh Redhu; Lianyu Shan; Duaa Al-Subait; Heather L Ashdown; Hesam Movassagh; Bouchaib Lamkhioued; Abdelilah S Gounni
Journal:  Allergy Asthma Clin Immunol       Date:  2013-10-17       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.